Neuro-Cognitive Center Director Presented Hadassah Model for Treating ADHD at International Biomedical Conference
Dr. Itai Berger
Representing Israel at the 2013 International TedMed Conference, which showcases innovations in medical and biotechnology, Dr. Itai Berger, Director of the Hadassah Medical Center's Neuro-Cognitive Center, presented Hadassah's model for treating attention deficit hyperactivity disorder (ADHD).
This is the first year that Israel has sent a delegation to the TedMed conference. More than 2,000 organizations and individuals applied to participate in this year's conference and only 20 delegates were chosen. Dr. Berger participated in what is known as "The Great Challenge Day" of the Conference, which features discussion groups devoted to particular specialties. Dr. Berger's group was entitled "Faster Adoption of Best Practices." He reports that his presentation was well received.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>